Select Your Region

Abbiamo rilevato che stai visitando questa pagina da United States. Seleziona la tua regione preferita per continuare.

Vai a United States (English)
vai al contenuto

Selezione paese

In base alla tua posizione

Europe

North America

Latin America

Asia-Pacific

Verifica del settore sanitario

Questa sezione contiene informazioni destinate agli operatori sanitari.

Si prega di confermare di far parte di un’azienda operante nel settore sanitario.

A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain)

In this publication, the authors determine the incidence of Sickle Cell Anemia and other structural hemoglobinopathies in the neonatal population of the Murcia region (Spain), and assess the benefit of newborn screening for SCD.

Pubblicato: 12/11/2026 | Modificato: 12/11/2026

This study evaluates the effectiveness of universal newborn screening for Sickle Cell Disease (SCD) in the Murcia region between 2016 and 2023. SCD is a hereditary blood disorder caused by hemoglobin S, which distorts red blood cells and leads to vaso-occlusive crises, organ damage, severe infections, and increased childhood mortality. Early diagnosis is essential, as preventive measures -such as penicillin prophylaxis and parental education- significantly improve the prognosis.

The study covered more than 100,000 newborns screened via Capillary Electrophoresis using heel-prick blood samples. The majority of the 500 cases detected and confirmed by genetic testing involved carriers, specifically of Hb S or Hb C. The prevalence of Sickle Cell Anemia (Hb SS) and Hb SC disease was estimated at approximatively 1 per 10,000 births.

The program also offered genetic counseling, although language and socioeconomic barriers sometimes limited participation. The authors conclude that universal screening enables early treatment, specialized follow-up, and improved prevention, thereby justifying its continued implementation in regions experiencing increased migration flows.

Test associated with this resource

Related instrument

Discover more resources on Hemoglobin Disorders

Questa sezione contiene informazioni destinate a un'ampia diffusione e potrebbe pertanto includere dettagli sui prodotti o informazioni non disponibili o non valide nel proprio Paese. Si prega di contattare il rappresentante Sebia di zona. Informazioni destinate agli operatori sanitari. Leggere attentamente le istruzioni riportate nei foglietti illustrativi dei reagenti e nei manuali degli strumenti.